Cassava Sciences News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cassava Sciences Inc SAVA NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.11 -0.31% 34.98 09:12:10
Open Price Low Price High Price Close Price Prev Close
more quote information »

Recent News

Date Time Source Heading
3/31/202116:26EDGARProxy Statement (definitive) (def 14a)
3/23/202117:06EDGARAnnual Report (10-k)
3/23/202109:28SEEKCassava Sciences EPS misses by $0.04
3/23/202108:55EDGARCurrent Report Filing (8-k)
3/23/202108:30GLOBECassava Sciences Announces Full-year 2020 Financial Results..
3/19/202120:34TRMNCassava: A Promising Yet Risky Alzheimer’s Pure Play
3/18/202116:07EDGARStatement of Changes in Beneficial Ownership (4)
3/18/202116:00EDGARStatement of Changes in Beneficial Ownership (4)
3/17/202108:00SEEKFTC moves to hinder cross-border pharma mergers; CVS cut to..
3/13/202109:20SEEKFull phase 2 data of Lilly's donanemab for Alzheimer's..
3/11/202117:00EDGARCurrent Report Filing (8-k)
3/09/202109:09SEEKCassava Sciences enters pharmaceutical supply agreement for..
3/09/202109:00GLOBECassava Sciences Announces Pharmaceutical Supply Agreement..
3/08/202108:30GLOBECassava Sciences to Present at the H.C. Wainwright Global..
2/26/202118:01TRMNCassava: Alzheimer Treatment’s Progress Merits a New Price..
2/23/202108:30GLOBECassava Sciences to Present at SVB Leerink Global Healthcare..
2/22/202111:49SEEKCassava Sciences outlines Pivotal Phase 3 trial design for..
2/22/202108:30GLOBECassava Sciences Announces Positive End-of-Phase 2 Meeting..
2/18/202119:25TRMNCassava: Potential Alzheimer Treatment Opens Door for..
2/16/202110:33SEEKCassava CEO Barber increases ownership stake; shares rise
2/16/202109:49EDGARAmended Statement of Ownership (sc 13g/a)
2/16/202108:04EDGARAmended Statement of Ownership (sc 13g/a)
2/12/202117:56EDGARCurrent Report Filing (8-k)
2/12/202117:08GLOBECassava Sciences Announces Closing of $200 Million..
2/11/202117:10EDGARAmended Statement of Ownership (sc 13g/a)
2/11/202106:04EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202115:37EDGARAmended Statement of Ownership (sc 13g/a)
2/10/202106:41SEEKCassava Sciences under pressure on raising $200M via..
2/10/202106:15GLOBECassava Sciences Announces $200 Million Registered Direct..
2/10/202106:07EDGARAutomatic Shelf Registration Statement of Securities of..
2/08/202116:10EDGARCurrent Report Filing (8-k)
2/08/202111:00SEEKCassava Sciences resumes winning streak after simufilam..
2/08/202108:30GLOBECassava Sciences Announces Significant Program Progress and..
2/05/202117:04EDGARStatement of Ownership (sc 13g)
2/05/202110:36TRMNCassava: Alzheimer’s Study Results Are Promising but It’s..
2/03/202109:18TRMNCassava Shares Go Through The Roof On Alzheimer Drug Trial..
2/02/202115:16EDGARStatement of Ownership (sc 13g)
2/02/202108:30GLOBECassava Sciences’ Simufilam Improves Cognition and Behavior..
1/04/202108:30GLOBECassava Sciences Appoints Dr. James Kupiec as Chief Clinical..
12/14/202017:07EDGARStatement of Changes in Beneficial Ownership (4)
12/14/202017:04EDGARStatement of Changes in Beneficial Ownership (4)
12/11/202016:44EDGARCurrent Report Filing (8-k)
11/27/202008:30GLOBEUSAN Modifies Lead Drug Candidate’s Chemical Name to..
11/23/202010:04EDGARStatement of Ownership (sc 13g)
11/13/202016:37EDGARCurrent Report Filing (8-k)
11/13/202009:08GLOBECassava Sciences Announces Pricing of $75 Million Public..
11/13/202006:10EDGARFree Writing Prospectus - Filing Under Securities Act Rules..
11/13/202006:08EDGARCurrent Report Filing (8-k)
11/12/202016:58EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
11/12/202016:48GLOBECassava Sciences Announces Proposed Public Offering of..
See more news about this stock »
Your Recent History
Cassava Sc..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210416 13:30:01